期刊文献+

丙戊酸钠合并米氮平或氟西汀治疗双相障碍抑郁发作的临床分析 被引量:1

下载PDF
导出
摘要 目的:评价米氮平合并丙戊酸钠治疗双相障碍抑郁发作的疗效和安全性。方法:将126例双相障碍抑郁发作患者分为两组,研究组61例,应用米氮平合并丙戊酸钠,对照组65例,应用氟西汀合并丙戊酸钠,治疗8周。结果:分别于治疗后第2、4、6、8周末用汉密尔顿抑郁量表(HAMD)总分比较,差异均有显著性(P〈0.05),研究组疗效优于对照组(P〈0.05),两组脱落率比较差异有显著性(P〈0.05),两组治疗后,各时期TESS总分比较差异均无显著性(P〉O.05),但研究组在治疗早期的嗜睡、困倦发生率较高、失眠发生率较低、胃肠道反应较少,治疗末体重增加较多(P〈0.05)。结论:米氮平合并丙戊酸钠治疗双相抑郁疗效肯定,不良反应较少,依从性好。
机构地区 鞍山市康宁医院
出处 《中国民康医学》 2009年第5期484-484,486,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献4

二级参考文献42

  • 1顾牛范,笪志民.米他扎品(Mirtazapine)—新抗抑郁药[J].上海精神医学,1996,8(4):258-261. 被引量:8
  • 2[1]Do Boer t, Ruit GSF, Berendsen HHG. The alph αa selective adrenoceptor antagonist Org 3770 (mirtazapine, Remeron) enhances noradrenergic and serotonergic transmission. Hum Psychopharmcol,1995, 10 (suppl2) : 107~118
  • 3[2]De Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychopharmacol, 1995, 10(suppl4) : 19~23
  • 4[3]Stahl S, Zivkov M, Reimitz PE, et al. Meta-analysis of randomized,double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression. Acta Psychiatr Scand (suppl), 1997, 391 : 22~30
  • 5[4]Leinonen E, skarstein J, Behnke K, et al. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group. Int Clin Psychopharmacol, 1999, 14 : 329~337
  • 6[5]Wheatley DP, Van Moffaert M, timmerman L, et al. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group. J Clin Psychiatry, 1998, 59: 306~312
  • 7[6]Kasper S. Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data. Int Clin Psychopharmacol, 1995, 10 (suppl 4) : 25~35
  • 8[7]Hoyberg OJ, Maragakis B, Mullin J, et al. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients. Acta Psycho Scand, 1996, 93 : 184~190
  • 9[8]Benkert O, Szegedi A, Kohnen R. Mirtazapine compared with paroxetine in major depression. J Clin Psychiatry, 2000 Sep, 61 (9) : 656~663
  • 10[9]Goodnick PJ, Puig A, DeVane CL, et al. Mirtazapine in major depression with comorbid generalized anxiety disorder. J Clin Psychiatry, 1999 Jul, 60(7) : 446~448

共引文献90

同被引文献15

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部